Sergey G. Kuznetsov
190 Rodionova St
Velikiy Novgorod, NGR 603126, Russian Federation
Velikiy Novgorod, NGR 603126, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Integrated hyperspectral-multispectral mapping of shear-associated hydrothermal alteration and gold mineralization validated by geochemical and isotopic data, southern Arabian Shield.
Journal: Scientific reports
Published: March 19, 2026
Possibilities of multiphoton microscopy for the diagnosis of the vulvar lichen sclerosus
Journal: Arkhiv patologii
Published: June 05, 2023
P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway.
Journal: Nucleic acids research
Published: November 23, 2022
Cross-Polarization Optical Coherence Tomography for Clinical Evaluation of Dermal Lesion Degrees in Vulvar Lichen Sclerosus.
Journal: Sovremennye tekhnologii v meditsine
Published: October 17, 2022
Box-Behnken assisted development and validation of high-performance liquid chromatography method for the simultaneous determination of doxorubicin and vorinostat in polymeric nanoparticles.
Journal: Journal of separation science
Published: September 09, 2022
Multimodal Optical Coherence Tomography for Intraoperative Evaluation of Tumor Margins and Surgical Margins in Breast-Conserving Surgery.
Journal: Sovremennye tekhnologii v meditsine
Published: January 01, 2022
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma.
Journal: Scientific reports
Published: April 08, 2021
Optical coherence angiography for pre-treatment assessment and treatment monitoring following photodynamic therapy: a basal cell carcinoma patient study.
Journal: Scientific reports
Published: July 24, 2019
Accurate early prediction of tumour response to PDT using optical coherence angiography.
Journal: Scientific reports
Published: November 11, 2018
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
Journal: International journal of cancer
Published: October 18, 2018
Last Updated: 09/26/2026